Autoplaque vs Affiniti Series Diagnostic Ultrasound Systems

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by Cedars-Sinai Medical Center: AIM

Affiniti Series Diagnostic Ultrasound Systems

by Philips Ultrasound

AI Verdict

Autoplaque is an AI-powered software for analyzing existing CT angiography images to quantify coronary plaque and stenosis, aiding in heart attack risk prediction. In contrast, the Philips Affiniti Series Diagnostic Ultrasound Systems are hardware-based ultrasound machines that acquire real-time diagnostic images for a wide range of clinical needs, including cardiology, OB/GYN, and radiology. While both tools are used in cardiology and leverage AI for enhanced diagnostics, Autoplaque is a post-processing software for CT images, whereas the Affiniti series is an ultrasound imaging system.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This workstation-based software is ideal for cardiologists and radiologists seeking to precisely characterize atherosclerotic plaque, measure stenoses, and aid in heart attack risk prediction and treatment guidance based on CT data.

View Autoplaque →

Choose Affiniti Series Diagnostic Ultrasound Systems if…

Choose Philips Affiniti Series Diagnostic Ultrasound Systems if you require a versatile, on-premise ultrasound solution for a wide range of clinical needs, including cardiology, OB/GYN, and general radiology. These systems offer advanced imaging with features like PureWave technology and Anatomical Intelligence, providing diagnostic confidence and efficient workflows for everyday ultrasound examinations.

View Affiniti Series Diagnostic Ultrasound Systems →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	Affiniti Series Diagnostic Ultrasound Systems
Pricing	Not disclosed	Varies by model and condition (new/refurbished). generally considered a 'mid tier' or 'budget' shared service ultrasound with rich image quality at an affordable price point compared to premium models.
Deployment	Workstation-based software, runs on Windows or Mac computer platforms	On-premise (console hardware system)
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems emphasize 'walk-up usability' and an intuitive interface, with studies showing minimal training needed for experienced users. The system also focuses on ergonomics, reducing button pushes and physical strain for sonographers. Autoplaque is a workstation-based software, and while it offers reviewable and editable segmentations, there is less emphasis on its overall user experience or ergonomic design in the provided information.

Clinical Value

Autoplaque

Autoplaque provides AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, directly aiding in heart attack risk prediction and treatment guidance. It has undergone clinical validation studies demonstrating excellent agreement with expert readers and correlation with outcomes. While Philips Affiniti offers advanced imaging and Anatomical Intelligence, its primary clinical value is in providing high-quality diagnostic images across diverse specialties, rather than a specific AI-driven risk prediction tool like Autoplaque.

Pricing & Value

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems offer transparent pricing, with specific ranges provided for refurbished models, and are generally considered a 'mid-tier' or 'budget' option with rich image quality. Autoplaque's pricing is not disclosed, making it difficult to assess its value proposition.

Enterprise Readiness

Affiniti Series Diagnostic Ultrasound Systems

Philips Affiniti Series Diagnostic Ultrasound Systems are HIPAA compliant and offer a Business Associate Agreement (BAA), indicating readiness for enterprise deployment and data security. Autoplaque's HIPAA compliance and BAA availability are not specified, which could be a significant hurdle for enterprise adoption. The Affiniti systems also offer structured reporting and DICOM capabilities for easy information sharing within a hospital network.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. Autoplaque leverages deep learning for automated and quantitative analysis of coronary plaque, a cutting-edge application in cardiology. Philips Affiniti Series incorporates innovations like PureWave crystal technology, Anatomical Intelligence Ultrasound, and NextGen Auto Scan for adaptive image optimization and efficient workflows.

Support & Docs

Affiniti Series Diagnostic Ultrasound Systems

Philips provides extensive documentation and support for its Affiniti Series, including DICOM conformance statements and user manuals, and emphasizes its award-winning service organization and remote monitoring capabilities. Autoplaque's documentation mentions a user manual and minimum hardware specifications, but a comprehensive support structure is not detailed.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	Affiniti Series Diagnostic Ultrasound Systems
Name	Autoplaque	Affiniti Series Diagnostic Ultrasound Systems
Company	Cedars-Sinai Medical Center: AIM	Philips Ultrasound
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The Philips Affiniti Series Diagnostic Ultrasound Systems offer advanced imaging for diverse clinical needs, featuring PureWave technology, Anatomical Intelligence, and efficient workflows for confident diagnosis.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, OB/GYN AI, Radiology & Imaging AI
Specialties	Cardiology, Radiology	Cardiology, Obstetrics & Gynecology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Affiniti Series Diagnostic Ultrasound Systems.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiologists and radiologists?

Autoplaque is a workstation-based post-processing application designed for cardiologists and radiologists to view and analyze cardiac CT data, functioning as an interactive tool for determining the presence and extent of coronary plaques and luminal stenoses. Philips Affiniti systems are designed for everyday ultrasound workflow, offering features like Tissue Specific Presets, Anatomical Intelligence, and automation tools such as AutoSCAN and SmartExam to streamline exams and reduce button pushes, aiming for efficient and intuitive operation.

What is the accuracy and sensitivity of each tool in its respective clinical application?

Autoplaque provides AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, and measurement of luminal stenoses from CT angiography images. While automatic plaque detection can have limitations with false positives and negatives, the automatic quantification of accurately detected plaques has shown reproducibility. Philips Affiniti systems offer advanced imaging with PureWave technology and Anatomical Intelligence, aiming for diagnostic confidence and reproducibility across diverse clinical needs. Specific accuracy and sensitivity metrics for Affiniti's diagnostic capabilities would depend on the particular application and transducer used.

What is the learning curve for physicians adopting these tools, and what training and support are available?

Autoplaque is intended for use by trained medical professionals, including cardiologists and radiologists, who have been appropriately trained in the software's functions, capabilities, and limitations. Philips Affiniti systems are designed for intuitive operation and 'walk-up' usability, with studies indicating that users with ultrasound experience require minimal training. Philips also offers e-training solutions in collaboration with LeQuest to provide hands-on experience with both hardware and software, covering system preparation, imaging modes, measurements, and patient examination review.

Beyond HIPAA, what are the security features and audit-trail capabilities of each tool?

Autoplaque's security posture beyond HIPAA is not specified in the provided information. Philips Affiniti systems offer enhanced audit logging capabilities, allowing users to configure the system to send logs to a local syslog server for retention and analysis. They also provide patient data encryption at rest and in transit, configurable access control levels, firewall policies, OS hardening, and optional malware protection.

How do these tools support multi-site rollout and consistent application across different clinical settings?

Autoplaque is a workstation-based software, running on Windows or Mac platforms, which suggests a deployment model that could be managed across multiple workstations. Philips Affiniti systems are console hardware systems, and Philips has introduced new automated tools and a common user interface coupled with transducer compatibility across its ultrasound systems, including Affiniti, to improve workflow and scanning efficiency across different locations.

What clinical context helps a physician choose between Autoplaque and Affiniti Series Diagnostic Ultrasound Systems?

Autoplaque is specifically designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. It helps quantify plaque and predict future cardiac events, especially non-ST-elevation myocardial infarction (NSTEMI). The Philips Affiniti Series Diagnostic Ultrasound Systems, on the other hand, are versatile diagnostic ultrasound systems offering advanced imaging for diverse clinical needs, including cardiology, obstetrics & gynecology, and radiology, with features like PureWave technology and Anatomical Intelligence.